Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06982235 · ClinicalTrials.gov registry record

Stone and Laser Therapies Post-Market Study (SALT)

A clinical trial of Renal Calculi and Benign Prostate Hypertrophy(BPH), sponsored by Boston Scientific Corporation.

Recruiting
Registry status
238
Enrollment target
5
Study locations

NCT06982235 is a study of Renal Calculi and Benign Prostate Hypertrophy(BPH) that is actively recruiting participants, run by Boston Scientific Corporation. The registered enrollment target is 238 participants, above the 207-participant average among 4 other Renal Calculi trials with a reported enrollment target (15% higher). The trial reports 5 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06982235, a study of Renal Calculi and Benign Prostate Hypertrophy(BPH), is actively recruiting participants, sponsored by Boston Scientific Corporation.

RECRUITING
Registry status
238 participants
Enrollment target
5
Study locations

Study Summary

The objective of the SALT Study is to obtain post-market safety and device performance data for Boston Scientific's Stone and BPH study devices used during a diagnostic and/or therapeutic urinary tract procedure (e.g., transurethral or percutaneous access routes) or benign prostatic hyperplasia (BPH) treatment.

Conditions Studied

Renal Calculi Benign Prostate Hypertrophy(BPH) Ureteral Stones, Kidney Stones Calculi, Urinary Urinary Tract Procedure

Interventions

  • DEVICE Ureteroscope system
  • DEVICE Laser system

Study Locations (5)

Florida

  • University of Miami Hospital - Miami
  • University of South Florida - Tampa

Arizona

  • Mayo Clinic Phoenix - Phoenix

Indiana

  • Indiana University Medical Center - Indianapolis

North Carolina

  • Duke University Medical Center - Durham

Trial Details

FieldValue
Enrollment Target 238 participants
Start Date 2025-06-30
Est. Completion 2029-02

Sponsor

Boston Scientific Corporation

280 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06982235

The ClinicalTrials.gov registry entry for NCT06982235 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 238 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 207-participant average among 4 other Renal Calculi trials with a reported enrollment target (15% higher). The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Renal Calculi appearing as the primary indexed condition, and to 2 interventions - of which Ureteroscope system is the first listed.

NCT06982235 reports 5 study locations spanning 4 distinct geographic areas - top geographies include Florida, Arizona, Indiana.

Frequently Asked Questions

What is clinical trial NCT06982235 about?

NCT06982235 is a clinical study titled "Stone and Laser Therapies Post-Market Study (SALT)". The objective of the SALT Study is to obtain post-market safety and device performance data for Boston Scientific's Stone and BPH study devices used during a diagnostic and/or therapeutic urinary tract procedure (e.g., transurethral or percutaneous access routes) or benign prostatic hyperplasia (BPH...

What is the current status of trial NCT06982235?

This trial is currently recruiting. The enrollment target is 238 participants. The study started on 2025-06-30. Estimated completion is 2029-02.

What conditions does trial NCT06982235 study?

This clinical trial studies the following conditions: Renal Calculi, Benign Prostate Hypertrophy(BPH), Ureteral Stones, Kidney Stones, Calculi, Urinary, Urinary Tract Procedure.

What interventions are being tested in trial NCT06982235?

The interventions under investigation include: Ureteroscope system (DEVICE), Laser system (DEVICE).

Who is sponsoring clinical trial NCT06982235?

This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06982235 being conducted?

This trial has 5 study locations across Arizona, Florida, Indiana, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Renal Calculi

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Renal Calculi

All registered trials for this condition

Benign Prostate Hypertrophy(BPH)

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.